Abstract
Background There is an ongoing pandemic of the viral respiratory disease COVID-19. People experiencing homelessness are vulnerable to infection and severe disease. Health and housing authorities in England have developed a residential intervention that aims to isolate those vulnerable to severe disease (COVID-PROTECT) and care for people with symptoms (COVID-CARE).
Methods We used a discrete-time Markov chain model to forecast COVID-19 infections among people experiencing homelessness, given strong containment measures in the general population and some transmission among 35,817 people living in 1,065 hostels, and 11,748 people sleeping rough (the ’do nothing’ scenario). We then estimated demand for beds if those eligible are offered COVID-PROTECT and COVID-CARE. We estimated the reduction in the number of COVID-19 cases, deaths, and hospital admissions that could be achieved by these interventions. We also conducted sensitivity and scenario analyses to identify programme success factors.
Results In a ’do nothing’ scenario, we estimate that 34% of the homeless population could get COVID-19 between March and August 2020, with 364 deaths, 4,074 hospital admissions and 572 critical care admissions. In our ’base intervention’ scenario, demand for COVID-PROTECT peaks at 9,934 beds, and demand for COVID-CARE peaks at 1,366 beds. The intervention could reduce transmission by removing symptomatic individuals from the community, and preventing vulnerable individuals from being infected. This could lead to a reduction of 164 deaths, 2,624 hospital admissions, and 248 critical care admissions over this period. Sensitivity analyses showed that the number of deaths is sensitive to transmission of COVID-19 in COVID-PROTECT. If COVID-PROTECT capacity is limited, scenario analyses show the benefit of prioritising people who are vulnerable to severe disease.
Conclusion Supportive accommodation can mitigate the impact of the COVID-19 pandemic on the homeless population of England, and reduce the burden on acute hospitals.
Competing Interest Statement
AS and AH have advocated for COVID-19 control measures among people experiencing homelessness. AH is a trustee of the homeless health charity Pathway.
Funding Statement
DL is funded by the National Institute for Health Research (NIHR) [Doctoral Research Fellowship DRF-2018-11-ST2-016]. IB is funded by an NIHR Academic Clinical Fellowship. This paper presents independent research. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. RWA was supported by the Wellcome Trust through a Wellcome Clinical Research Career Development Fellowship [206602]. ME is funded by a studentship from the Medical Research Council, United Kingdom.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding DL is funded by the National Institute for Health Research (NIHR) [Doctoral Research Fellowship DRF-2018–11-ST2–016]. IB is funded by an NIHR Academic Clinical Fellowship. This paper presents independent research. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. RWA was supported by the Wellcome Trust through a Wellcome Clinical Research Career Development Fellowship [206602]. ME is funded by a studentship from the Medical Research Council, United Kingdom.
Declaration of interests AS and AH have advocated for COVID-19 control measures among people experiencing homelessness. AH is a trustee of the homeless health charity Pathway.
Data Availability
All data and code has been made publicly available.
